Aurobindo Pharma gets USFDA final approval for Perampanel tablets

Drugmaker to launch the approved product in Q3 FY27; product has estimated US market size of $67 million, according to IQVIA MAT

Leave a Reply

Your email address will not be published. Required fields are marked *